No | Age | Specimen | Accompanying disease | Site of acquisition | ESBL genotype | Plasmid type | ST131 (O25b/O16) |
---|---|---|---|---|---|---|---|
C05 | 39 | Cervix | Preterm labor | CA | CTX-M − 15 | – | Non ST131 |
C08 | 45 | Cervix | Malaria | CA | CTX-M − 15 | – | Non ST131 |
C12 | 96 | Cervix | Cervix cancer, pneumonia | COHA | CTX-M − 15 | IncFI, IncI1-Iγ, | ST131 (O25b) |
C15 | 32 | Cervix | Preterm labor | CA | CTX-M − 55 | IncFII | Non ST131 |
C24 | 42 | Cervix | Pelvic inflammatory disease | CA | CTX-M − 15 | – | Non ST131 |
C29 | 54 | Cervix | Atrophic vaginitis | CA | CTX-M − 15 | IncI1-Iγ, | ST131 (O25b) |
C34 | 31 | Cervix | Preterm labor | CA | CTX-M − 55 | IncI1-Iγ, | ST131 (O16b) |
C36 | 51 | Cervix | Recurrent vaginitis, UTI | CA | CTX-M − 15 | – | Non ST131 |
C39 | 86 | Cervix | Endometritis | COHA | CTX-M − 15 | IncFII | ST131 (O25b) |
C43 | 32 | Cervix | Recurrent vaginitis, UTI | COHA | CTX-M − 15 | non-typable | ST131 (O25b) |
C50 | 34 | Cervix | Pelvic inflammatory disease | CA | CTX-M − 15 CTX-M-27 | – | Non ST131 |
C60 | 68 | Cervix | Atrophic vaginitis | CA | CTX-M − 15 | – | ST131 (O16) |
C71 | 45 | Cervix | Atrophic vaginitis | CA | CTX-M − 15 | – | Non ST131 |
C72 | 46 | Cervix | Recurrent vaginitis | CA | CTX-M-15 | IncFI | Non ST131 |
C73 | 45 | Cervix | Recurrent vaginitis | CA | CTX-M − 15 | – | Non ST131 |
C77 | 32 | Cervix | Pelvic inflammatory disease | CA | CTX-M − 15 | IncFII | ST131 (O16) |
C79 | 42 | Cervix | Pelvic inflammatory disease | CA | CTX-M − 15 | IncFII | Non ST131 |
C96 | 86 | Endometrium | Atrophic vaginitis | COHA | CTX-M − 55 | IncFI | Non ST131 |